• Chenodeoxycholic Acid in Renal and Metabolic Research Workfl

  2026-06-21

  Chenodeoxycholic Acid (CDCA) is redefining nuclear receptor signaling and renal protection, empowering researchers to model and modulate the FXR-KLF11 axis in acute kidney injury and cholesterol metabolism. This article details protocol enhancements, troubleshooting insights, and translational applications for maximizing data quality using APExBIO’s high-quality CDCA.

• Leucomycin (Kitasamycin): Precision in Translational Inhibit

  2026-06-20

  Explore the unique properties and advanced assay applications of Leucomycin (kitasamycin), a potent macrolide antibiotic. Discover new insights into impurity analysis and practical guidance for translational inhibition studies.

• Murine RNase Inhibitor: Oxidation-Resistant RNA Protection

  2026-06-19

  Murine RNase Inhibitor (K1046) is a recombinant mouse protein that provides robust, oxidation-resistant RNA degradation prevention in molecular biology workflows. Its specificity for pancreatic-type RNases and stability under low reducing conditions make it a preferred RNase A inhibitor for sensitive applications like real-time RT-PCR and cDNA synthesis.

• 2'3'-cGAMP (sodium salt): Unmasking Tumor Immune Evasion

  2026-06-19

  Explore how 2'3'-cGAMP (sodium salt) enables advanced dissection of tumor-driven immune evasion via the cGAS-STING pathway. This article reveals practical and mechanistic insights for immunology and cancer research, grounded in the latest exosomal ENPP1 discoveries.

• Cabozantinib XL184: Optimizing Kinase Inhibition in RCC Mode

  2026-06-18

  Harness Cabozantinib’s multi-kinase targeting to dissect timescale-dependent signaling and cell motility adaptation in renal cell carcinoma. Implement robust, phosphoproteomics-ready workflows and troubleshoot resistance with insights from the latest systems-level studies.

• Strategic Lysosome Tracking: Translational Power of Lyso-Tra

  2026-06-18

  This thought-leadership article explores the frontier of live-cell lysosome imaging, spotlighting Lyso-Tracker Red’s pivotal role in decoding disease-relevant lysosomal dynamics. It weaves mechanistic insights from recent advances in cancer immunotherapy with actionable, protocol-driven guidance for translational researchers, while positioning APExBIO’s probe as an indispensable tool for next-generation biomedical discovery.

• Pazopanib (GW-786034) in Cancer Research: Workflow and Insig

  2026-06-17

  Pazopanib (GW-786034) empowers oncology researchers with robust, selective inhibition of key angiogenic and proliferative pathways, enabling advanced studies on tumor growth suppression and therapeutic synergy. Recent findings in ATRX-deficient glioma models reveal new dimensions for precision targeting, while optimized protocols from APExBIO ensure reproducible, high-impact experimental outcomes.

• Transmission Dynamics of Carbapenemase Genes in CREC in Chin

  2026-06-17

  This study systematically characterizes the prevalence and transmission mechanisms of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) across eight hospitals in Guangdong Province during 2022–2024. The findings reveal a high frequency of multidrug resistance and efficient gene transfer, highlighting critical challenges for infection control and antibiotic stewardship.

• Unlocking Drug Discovery with DiscoveryProbe Natural Product

  2026-06-16

  DiscoveryProbe Natural Product Library Plus empowers researchers with a broad, cell-permeable compound selection, ready for high-throughput screening. Its rigorously validated, DMSO pre-dissolved plates accelerate hit identification, especially for challenging targets like protozoan enzymes.

• Wnt Agonist 1 (BML-284): Precision Tools for Wnt Pathway Res

  2026-06-16

  Wnt agonist 1 (BML-284) enables reproducible, high-fidelity activation of the canonical Wnt signaling pathway for studies in cell differentiation, developmental biology, and chemoresistance. This guide details evidence-backed experimental workflows, optimization strategies, and troubleshooting tips, making it an essential resource for advanced Wnt pathway cellular differentiation research.

• Triacetin (Glyceryl Triacetate): Metabolic Modulation & Rese

  2026-06-15

  Explore the unique metabolic potential of Triacetin (glyceryl triacetate) in biochemical research, focusing on its role as a metabolic modulator and its implications for advanced life science assays. This article delivers new insights and practical protocols grounded in recent scientific breakthroughs.

• SAR131675: Precision VEGFR-3 Inhibition in Angiogenesis Rese

  2026-06-15

  SAR131675 delivers unmatched selectivity as a VEGFR-3 inhibitor, empowering researchers to dissect lymphangiogenesis and tumor progression with high fidelity. This article offers protocol enhancements, troubleshooting insights, and a translational bridge from nicotine-driven CKD research to vascular targeting strategies.

• Carbapenemase Genes in CREC: Transmission Dynamics in Guangd

  2026-06-14

  This study provides a comprehensive genomic and epidemiological characterization of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China. Key innovations include mapping the prevalence, genetic context, and horizontal transfer rates of blaNDM-1 and other resistance determinants during the COVID-19 pandemic, informing both molecular surveillance and experimental approaches to multidrug resistance.

• Distinct Metrics for Evaluating Cancer Drug Effects In Vitro

  2026-06-13

  Schwartz's dissertation introduces a rigorous distinction between proliferative arrest and cell death when assessing in vitro drug responses in cancer models. This approach clarifies the interpretation of anti-cancer compound efficacy and offers pathways for improved assay design in translational research.

• Standardized Whole-Blood Stimulation Reveals Metabolic Contr

  2026-06-12

  The reference study establishes a reproducible protocol for analyzing immune responses in human whole blood under metabolic modulation, with a focus on standardized workflows and robust cytokine profiling. This approach enables precise interrogation of how metabolic inhibitors, such as those blocking fatty acid oxidation, selectively shape immune cell function and cytokine output, supporting translational immunometabolism research.

14582 records 3/973 page Previous Next 12345 下5页 Last page